WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

ROLE OF MATRA BASTI ON KASHTARTAVA

Patil Veena Ajay, Kulkarni Chhaya Sudhakar, Prajapati Chanda Tirathram and Birajdar Balaji Baburao*

Abstract

Kashtartava is the term which covers all the problems and aliments that a woman may suffer from during or around menstruation. It includes both primary and secondary dysmenorrhoea. But we only considered primary dysmenorrhoea under the term kashtartava. Dysmenorrhoea is most common gynaecological problem faced by women during their adolescence. This causes great discomfort and anxiety for woman. It can also create emotional distress brought on by the pain & may result in missing work or school or other activities. The treatment for dysmenorrhoea in modern medicine is oral contraceptives pills, non-steroidal anti- inflammatory drugs, anti-spasmodic, analgesics etc. Long term use of these medicines causes side effect. The main features of kashtartava is the pain. Hence it has strong relation with vatadosha. Keeping this point in mind vatashamaka treatment may be very effective for kashtartava. Basti is a reliable treatment for vatashamana. Matrabasti can be used as a safe & effective therapeutic agent in the management of kashtartava.

Keywords: Matra Basti, Dysmenorrhoea, Kashtartava, Pain, Vatadosha.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More